A take-home placebo treatment can reduce stress, anxiety and symptoms of depression in a non-patient population
The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Background: With a healthcare system burdened by symptomatic and mental-health related conditions, the placebo effect may represent a useful clinical tool. First, however, there is a need to broaden research attention and investigate placebo effects outside laboratories and beyond experimental pain. This study investigated the effectiveness of a take-home placebo treatment in the short-term alleviation of stress, anxiety and symptoms of depression in a non-patient population. Method: A sample of 77 participants was randomized to either the ‘oxytocin’ treatment group ( n = 22), the ‘serotonin’ treatment group ( n = 22) or the wait-list control group ( n = 33). The two treatment groups were given an ‘anti-stress treatment spray’ (placebo) to self-administer for 3 days, and completed online measures of perceived stress (Perceived Stress Scale-10), anxiety (Cognitive Somatic Anxiety Questionnaire) and symptoms of depression (Centre for Epidemiological Studies – Depression) before and after the 3-day protocol. Results: Both the ‘serotonin’ and ‘oxytocin’ treatment sprays were effective in reducing symptoms of depression; however, only those in the ‘oxytocin’ group reported less stress and anxiety as compared with controls. Overall, the ‘oxytocin’ was perceived as more effective. Conclusion: Placebo effects can be translated to a real-life setting in the short-term reduction of stress, anxiety and symptoms of depression in a non-patient population. In treating psychological distress, placebos may be useful addition to the treatment repertoire. The information given with treatment may also be an important consideration for practitioners.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The placebo effect is commonly reported across human health research and has been specifically reported for stress [23, 24].”
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267 · cited 3×
“In considering the clinical applicability of this study, findings are limited by the use of a non-patient sample; however, the baseline depression scores were high, with the average across the whole sample above the standard screening cut-off point of 16 (Radloff, 1977).”
MethodInfluentialA Global Measure of Perceived Stress
Cohen, S., Kamarck, T., & Mermelstein, R. (1983) · Journal of Health and Social Behavior · doi:10.2307/2136404 · Cited by 32,807 · cited 2×
“Internal consistency for the PSS was good on Day 1 (α = 0.80) and Day 5 (α = 0.86) Depressive symptoms.”
BackgroundInfluentialCochrane Database of Systematic Reviews
(2011) · Progress in Neurology and Psychiatry · doi:10.1002/pnp.208 · Cited by 4,667
Smith, K. P., & Christakis, N. A. (2008) · Annual Review of Sociology · doi:10.1146/annurev.soc.34.040507.134601 · Cited by 1,638 · cited 2×
“, 2008), and social networks and social connectedness have been repeatedly linked to better outcomes in depression (Santini et al., 2015; Smith and Christakis, 2008).”
BackgroundFerrari, A. J., Somerville, A. J., Baxter, A. J., Norman, R., Patten, S. B., Vos, T., & Whiteford, H. A. (2013) · Psychological Medicine · doi:10.1017/s0033291712001511 · Cited by 1,230 · cited 1×
“Treating ailments such as stress, anxiety and depression can be difficult, not only because they are pervasive and debilitating (Ferrari et al., 2013; Santini et al., 2015), but because standard-care pharmacological approaches may not always be optimal or effective.”
BackgroundThe association between social relationships and depression: A systematic review
Santini, Z. I., Koyanagi, A., Tyrovolas, S., Mason, C., & Haro, J. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.049 · Cited by 949 · cited 3×
“Treating ailments such as stress, anxiety and depression can be difficult, not only because they are pervasive and debilitating (Ferrari et al., 2013; Santini et al., 2015), but because standard-care pharmacological approaches may not always be optimal or effective.”
BackgroundBarsky, A. J., Orav, E. J., & Bates, D. W. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.8.903 · Cited by 911 · cited 1×
“Psychiatric and psychologically influenced conditions represent a significant healthcare burden (Barsky et al., 2005; Milczarek et al., 2009; Nimnuan et al., 2001; World Health Organization, 2001).”
BackgroundPlacebos without Deception: A Randomized Controlled Trial in Irritable Bowel Syndrome
Kaptchuk, T. J., Friedlander, E., Kelley, J. M., Sanchez, M. N., Kokkotou, E., Singer, J. P., Kowalczykowski, M., Miller, F. G., Kirsch, I., & Lembo, A. J. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015591 · Cited by 900 · cited 2×
“…improvements in IBS symptomology after participants were told they had been given an inert substance, but that the treatment has ‘been shown in rigorous clinical testing to produce significant improvement in IBS symptoms through mind-body self-healing processes’ (Kaptchuk et al., 2010: 2).”
BackgroundPlacebo interventions for all clinical conditions
Hróbjartsson, A., & Gøtzsche, P. C. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003974.pub3 · Cited by 777
The organization of the stress system and its dysregulation in depressive illness
Gold, P. W. (2015) · Molecular Psychiatry · doi:10.1038/mp.2014.163 · Cited by 654 · cited 2×
“, 2008), with chronic stress and a dysregulated physiological stress system a factor in the development of depression (Gold, 2015).”
BackgroundMedically unexplained symptoms
Nimnuan, C., Hotopf, M., & Wessely, S. (2001) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(01)00223-9 · Cited by 622 · cited 1×
“Psychiatric and psychologically influenced conditions represent a significant healthcare burden (Barsky et al., 2005; Milczarek et al., 2009; Nimnuan et al., 2001; World Health Organization, 2001).”
BackgroundOvert versus covert treatment for pain, anxiety, and Parkinson's disease
Colloca, L., Lopiano, L., Lanotte, M., & Benedetti, F. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00908-1 · Cited by 552 · cited 2×
“Placebos have been shown to reduce acute stress and anxiety in lab settings (Colloca et al., 2004; Darragh et al., 2014; Petrovic et al., 2005); however, in the real-world, depressed, stressed or anxious patients are required to self-administer treatments around their daily activities and amidst…”
BackgroundPlacebo and the New Physiology of the Doctor-Patient Relationship
Benedetti, F. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2012 · Cited by 492 · cited 1×
“The placebo phenomenon has shown that the act of administering treatment, regardless of its properties, can deliver health benefits (Benedetti, 2002, 2013).”
BackgroundPetrovic, P., Dietrich, T., Fransson, P., Andersson, J., Carlsson, K., & Ingvar, M. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.023 · Cited by 437 · cited 1×
“Placebos have been shown to reduce acute stress and anxiety in lab settings (Colloca et al., 2004; Darragh et al., 2014; Petrovic et al., 2005); however, in the real-world, depressed, stressed or anxious patients are required to self-administer treatments around their daily activities and amidst…”
BackgroundSchwartz, G. E., Davidson, R. J., & Goleman, D. J. (1978) · Psychosomatic Medicine · doi:10.1097/00006842-197806000-00004 · Cited by 393 · cited 2×
“Internal consistency for the CSAQ was good on both Days 1 and 5 (αs = 0.85)”
BackgroundInfluentialMeta-analysis of the placebo response in antidepressant trials.
Rief, W., Nestoriuc, Y., Weiss, S., Welzel, E., Barsky, A. J., & Hofmann, S. G. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.029 · Cited by 346 · cited 2×
“, 2014); and meta-analyses of clinical depression trials report limited benefits of antidepressants over placebos for people who are mildly to moderately depressed (Kirsch, 2010; Rief et al., 2009).”
BackgroundSchedlowski, M., Enck, P., Rief, W., & Bingel, U. (2015) · Pharmacological Reviews · doi:10.1124/pr.114.009423 · Cited by 323 · cited 1×
“Furthermore, placebo responses in clinical trials for anxiety disorders can be up to 60%, with long lasting and clinically relevant effects observed in some trials (Schedlowski et al., 2015).”
BackgroundMcRae, C., Cherin, E., Yamazaki, T. G., Diem, G., Vo, A. H., Russell, D., Ellgring, J. H., Fahn, S., Greene, P., Dillon, S., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.4.412 · Cited by 278 · cited 1×
“Prior work has shown that a patient’s belief in the effectiveness of their treatment is an important part of their actual effectiveness (McRae et al., 2004).”
BackgroundPlacebo Effects – Understanding the Mechanisms in Health and Disease
(2016) · physioscience · doi:10.1055/s-0035-1567078 · Cited by 270
Cvetkovski, S., Reavley, N. J., & Jorm, A. F. (2012) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867411435290 · Cited by 252 · cited 1×
“Together, this increases confidence that these findings offer clinical utility, and at least might be applicable to mildly depressed students, who are known to experience higher rates of moderate psychological distress (Cvetkovski et al., 2012).”
BackgroundDour, H. J., Wiley, J. F., Roy-Byrne, P., Stein, M. B., Sullivan, G., Sherbourne, C. D., Bystritsky, A., Rose, R. D., & Craske, M. G. (2014) · Depression and Anxiety · doi:10.1002/da.22216 · Cited by 243 · cited 1×
“Perceived social support can ameliorate symptoms of anxiety (Dour et al., 2014) and attenuate the impact of stressors in laboratory contexts (Thorsteinsson and James, 1999).”
BackgroundHu, X. H., Bull, S. A., Hunkeler, E. M., Ming, E., Lee, J. Y., Fireman, B., & Markson, L. E. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0712 · Cited by 235 · cited 1×
“For example, in some cases, antidepressants may not deliver benefits over no-treatment in the long term (Hughes and Cohen, 2009), and there can be negative effects associated with long-term medication use (Cascade et al., 2009; Hu et al., 2004).”
BackgroundThe power of context: reconceptualizing the placebo effect
Miller, F. G., & Kaptchuk, T. J. (2008) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.070466 · Cited by 229 · cited 2×
“Australian & New Zealand Journal of Psychiatry, 50(9) psychosocial context of treatment (Colloca and Miller, 2011b; Kaptchuk, 2011; Miller and Kaptchuk, 2008) can generate positive changes in the absence of pharmacological agents.”
BackgroundPlacebo Effects: Understanding the Mechanisms in Health and Disease
Ernst, E. (2009) · Focus on Alternative and Complementary Therapies · doi:10.1111/j.2042-7166.2009.tb05272.x · Cited by 227 · cited 1×
“One issue to be overcome is that placebo effects are not often directly investigated in depressed and anxious patients because of the ethical issues inherent to deceiving vulnerable populations (Benedetti, 2009).”
BackgroundThorsteinsson, E. B., & James, J. E. (1999) · Psychology & Health · doi:10.1080/08870449908407353 · Cited by 201 · cited 2×
“Perceived social support can ameliorate symptoms of anxiety (Dour et al., 2014) and attenuate the impact of stressors in laboratory contexts (Thorsteinsson and James, 1999).”
BackgroundKaptchuk, T. J. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0385 · Cited by 174 · cited 2×
“Australian & New Zealand Journal of Psychiatry, 50(9) psychosocial context of treatment (Colloca and Miller, 2011b; Kaptchuk, 2011; Miller and Kaptchuk, 2008) can generate positive changes in the absence of pharmacological agents.”
BackgroundHow the doctor's words affect the patient's brain
Benedetti, F. (2002) · Evaluation & the Health Professions · doi:10.1177/0163278702238051 · Cited by 173 · cited 1×
“The placebo phenomenon has shown that the act of administering treatment, regardless of its properties, can deliver health benefits (Benedetti, 2002, 2013).”
BackgroundReal-World Data on SSRI Antidepressant Side Effects.
Cascade, E. F., Kalali, A. H., & Kennedy, S. H. (2009) · PubMed · Cited by 169
Deception in Research on the Placebo Effect
Miller, F. G., Wendler, D., & Swartzman, L. C. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020262 · Cited by 168 · cited 3×
“More broadly, the question of how to transfer placebo effects into clinical contexts represents a substantial ethical and practical hurdle (Colloca and Miller, 2011a; Miller et al., 2005).”
BackgroundExpectations and associations that heal: Immunomodulatory placebo effects and its neurobiology
Pacheco-López, G., Engler, H., Niemi, M.-B., & Schedlowski, M. (2006) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.05.003 · Cited by 164
Role of expectations in health
Colloca, L., & Miller, F. G. (2011) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e328343803b · Cited by 161 · cited 3×
“More broadly, the question of how to transfer placebo effects into clinical contexts represents a substantial ethical and practical hurdle (Colloca and Miller, 2011a; Miller et al., 2005).”
BackgroundMechanisms of the placebo response and their impact on clinical trials and clinical practice
Finniss, D. G., & Benedetti, F. (2005) · Pain · doi:10.1016/j.pain.2004.12.012 · Cited by 150 · cited 2×
“, 2006) and activating endogenous healing processes (Finniss and Benedetti, 2005), may be a useful way to explain how supposedly ‘inert’ treatments can exert real effects on health outcomes; and could highlight the role a patient plays in improving their condition.”
BackgroundMechanisms Involved in Placebo and Nocebo Responses and Implications for Drug Trials
Rief, W., Bingel, U., Schedlowski, M., & Enck, P. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2011.204 · Cited by 134 · cited 1×
“Changes in depressive symptoms occur naturally, meaning the use of a no-treatment (or waitlist) control group is a vital component of determining a treatment’s efficacy (Rief et al., 2011).”
BackgroundAsberg, K. K., Bowers, C. A., Renk, K., & McKinney, C. (2008) · Child Psychiatry & Human Development · doi:10.1007/s10578-008-0102-0 · Cited by 129 · cited 3×
“There are clear overlaps between perceived (or psychological) stress, anxiety and depression (Asberg et al., 2008), with chronic stress and a dysregulated physiological stress system a factor in the development of depression (Gold, 2015).”
BackgroundHarnessing the placebo effect: the need for translational research
Colloca, L., & Miller, F. G. (2011) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2010.0399 · Cited by 125 · cited 3×
“More broadly, the question of how to transfer placebo effects into clinical contexts represents a substantial ethical and practical hurdle (Colloca and Miller, 2011a; Miller et al., 2005).”
BackgroundLeuchter, A. F., Hunter, A. M., Tartter, M., & Cook, I. A. (2014) · British Journal of Psychiatry · doi:10.1192/bjp.bp.113.140343 · Cited by 86 · cited 2×
“…shows that in the treatment of depression, placebos used adjunctively with supportive care sessions can be just as effective as ‘active’ medications (Leuchter et al., 2014); and meta-analyses of clinical depression trials report limited benefits of antidepressants over placebos for people who are…”
BackgroundA systematic review of long-term studies of drug treated and non-drug treated depression
Hughes, S., & Cohen, D. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.01.027 · Cited by 71 · cited 2×
“For example, in some cases, antidepressants may not deliver benefits over no-treatment in the long term (Hughes and Cohen, 2009), and there can be negative effects associated with long-term medication use (Cascade et al.”
BackgroundInvestigating the ‘placebo personality’ outside the pain paradigm
Darragh, M., Booth, R. J., & Consedine, N. S. (2014) · Journal of Psychosomatic Research · doi:10.1016/j.jpsychores.2014.02.011 · Cited by 53 · cited 2×
“Placebos have been shown to reduce acute stress and anxiety in lab settings (Colloca et al., 2004; Darragh et al., 2014; Petrovic et al., 2005); however, in the real-world, depressed, stressed or anxious patients are required to self-administer treatments around their daily activities and amidst…”
BackgroundSelf-citationReview: benefits of antidepressants over placebo limited except in very severe depression
Kirsch, I. (2010) · Evidence-Based Mental Health · doi:10.1136/ebmh.13.2.49 · Cited by 9 · cited 2×
“, 2014); and meta-analyses of clinical depression trials report limited benefits of antidepressants over placebos for people who are mildly to moderately depressed (Kirsch, 2010; Rief et al., 2009).”
Background
Research works printed but not linked: 1
- Cascade E, 2009, Psychiatry (Edgmont), 6, 16
Cited by
Placebos Without Deception: Outcomes, Mechanisms, and Ethics
Colloca, L., & Howick, J. (2018) · International Review of Neurobiology · doi:10.1016/bs.irn.2018.01.005 · Cited by 108
“Other factors are also likely to play a role, including biopsychosocial forces arising from contact with a healthcare practitioner (Holt-Lunstad, Smith, & Layton, 2010), and lowered patient anxiety due to a positive expectation of recovery (Benedetti, Carlino, & Pollo, 2011; Darragh et al., 2016).”
BackgroundGaab, J., Kossowsky, J., Ehlert, U., & Locher, C. (2019) · Scientific Reports · doi:10.1038/s41598-018-37945-1 · Cited by 86
Affect and emotions in placebo and nocebo effects: What do we know so far?
Geers, A. L., Faasse, K., Guevarra, D. A., Clemens, K. S., Helfer, S. G., & Colagiuri, B. (2020) · Social and Personality Psychology Compass · doi:10.1111/spc3.12575 · Cited by 60
Haas, J. W., Rief, W., Glombiewski, J. A., Winkler, A., & Doering, B. K. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.05.056 · Cited by 41
Placebo prevents rumination: An experimental study
Lea, R., Schäfer, L. N., Κube, T., Ehmke, V., & Rief, W. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.06.010 · Cited by 29
Metadata
- Authors
- Darragh, M., Yow, B., Kieser, A., Booth, R. J., Kydd, R. R., & Consedine, N. S.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Consedine, Nathan S
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2016-07-19
- Volume
- 50
- Issue
- 9
- Pages
- 858-865
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W2203940360
- Cited by
- 21
- References
- 39
- Citations by year
- 2026: 3 · 2024: 2 · 2023: 5 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 1
- FWCI
- 0.20
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Australian & New Zealand Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Pain Management and Placebo Effect
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Keywords
- placebo effect, perceived stress, anxiety, depressive symptoms, psychological distress
- MeSH terms
- Adult, Anxiety, Depression, Humans, Placebos, Stress, Psychological, Placebo Effect, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.